Gene: SLCO4A1
Official Full Name: solute carrier organic anion transporter family member 4A1provided by HGNC
Gene Summary: Enables organic anion transmembrane transporter activity and prostaglandin transmembrane transporter activity. Predicted to be involved in sodium-independent organic anion transport. Predicted to be located in plasma membrane. Predicted to be active in basolateral plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27466 | SLCO4A1 Knockout cell line (HeLa) | Human | SLCO4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO27467 | SLCO4A1 Knockout cell line (HCT 116) | Human | SLCO4A1 | 1:2~1:4 | Negative | Online Inquiry |
KO27468 | SLCO4A1 Knockout cell line (HEK293) | Human | SLCO4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO27469 | SLCO4A1 Knockout cell line (A549) | Human | SLCO4A1 | 1:3~1:4 | Negative | Online Inquiry |
SLCO4A1 Gene Knockout Cell Lines are genetically engineered models specifically designed to study the function and regulation of the SLCO4A1 gene, which encodes for a member of the solute carrier organic anion transporter family. These knockout cell lines contain targeted deletions of the SLCO4A1 gene, thereby eliminating its expression and providing researchers with a powerful tool to investigate the gene's role in various biological processes and its implications in disease.
The primary mechanism of action for these knockout cell lines involves the absence of the SLCO4A1 protein, which is implicated in the transport of organic anions and various therapeutic agents across cellular membranes. This lack of expression allows for the assessment of the cellular pathways affected by the loss of SLCO4A1, facilitating insights into drug disposition, metabolism, and the pathophysiological roles associated with this transporter. By utilizing these cell lines, researchers can conduct experiments to evaluate drug interactions, signaling pathways, and responses to pharmacological agents in a controlled environment.
The scientific importance of SLCO4A1 Gene Knockout Cell Lines spans across both research and clinical settings. In drug development, these models can help predict drug efficacy and safety by simulating patient responses to medications that transit through the SLCO4A1 pathway. Moreover, their applications extend to the study of diseases such as cancer, where altered expression of transporters can affect therapeutic outcomes.
Compared to conventional wild-type cell lines, these knockout models provide a unique advantage in precision and specificity for analyzing the consequences of SLCO4A1 inhibition. They allow researchers to obtain clearer, more interpretable results pertaining to gene function and to evaluate the therapeutic potential of targeting the SLCO4A1 pathway.
For researchers and clinicians aiming to advance their understanding of drug transport mechanisms and their implications in health and disease, SLCO4A1 Gene Knockout Cell Lines represent an invaluable resource. Our company specializes in the generation of high-quality genetic models, backed by years of expertise in molecular biology and a commitment to supporting innovative research solutions. By integrating cutting-edge technology with detailed scientific knowledge, we ensure that our products meet the highest standards of reliability and efficacy, enabling users to achieve impactful results in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.